Trichinosis Workup

  • Author: Clinton Murray, MD; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Jan 4, 2010
 

Laboratory Studies

  • Obtain a CBC count.
    • Leukocytosis occurs in 65% of patients, with cell counts of up to 24,000/µL.
    • Eosinophilia typically rises 10 days after infection, with total eosinophil counts of up to 8700/µL (40%-80% of total WBC). The counts peak in 3-4 weeks and resolve over the next few months.
    • Nearly all patients with trichinosis, either symptomatic or asymptomatic, exhibit eosinophilia. The only exception is in severe cases, when the eosinophil count may be severely depressed. A low eosinophil count indicates an increased mortality rate.
  • Erythrocyte sedimentation rates are usually within the reference range.
  • Obtain creatine kinase (CK) levels.[7]
    • CK levels are elevated to 17,000 U/L.
    • CK (isoenzyme myocardial band [MB]) elevations may indicate myocardial involvement; however, as many as 35% of patients without cardiac involvement may have elevated CK-MB levels.
  • Levels of lactate dehydrogenase isoenzymatic forms (ie, lactate dehydrogenase fraction 4 [LD4] and lactate dehydrogenase fraction 5 [LD5]) are elevated in 50% of patients.
  • Immunoglobulin E levels are typically elevated.
  • Serology results are not positive until 2-3 weeks after infection. They peak around the third month and may persist for years.
  • Serology ratios do not correlate with the severity of disease or the clinical course. However, a strong positive test result usually indicates an early infection.
    • Perform indirect hemagglutination.
    • Bentonite flocculation results are usually not positive for more than 1 year after infection.
    • Perform indirect immunofluorescence.
    • Latex agglutination results are usually not positive for more than 1 year after infection.
    • Enzyme-linked immunosorbent assay (ELISA) is 100% sensitive on day 50, with 88% of results remaining positive 2 years after infection.
  • The immediate hypersensitivity skin test is no longer commercially available. Reactions results are positive (5 mm) at approximately day 17 and remain positive for life.
  • Molecular techniques are being developed but have not been validated.
Next

Imaging Studies

  • In patients with CNS involvement, CT scanning and MRI with contrast enhancement may reveal 3- to 8-mm nodular or ringlike lesions.
Previous
Next

Other Tests

  • Electrocardiography
    • Premature contractions
    • Prolongation of the PR intervals
    • Small QRS complexes with intraventricular block
    • Flattening or inversion of the T waves, especially lead II and precordial leads
  • Polymerase chain reaction
    • Useful for isolating the parasite and subsequent genetic typing
    • Primarily a research tool
Previous
Next

Procedures

  • Electromyelography
    • Electromyelography may be helpful in diagnosing moderate-to-severe infection, but no pathognomonic findings exist. The test result may reveal acute myositis or diffuse myopathic dysfunction.
    • Changes usually resolve 2-3 months after infection but may persist for 1-8 years.
  • Lumbar puncture (to evaluate for suspected neurologic disease)
    • Results are normal in 50%-75% of patients.
    • Larvae are found in 8%-24% in patients.
    • Eosinophilic meningitis may be present.
  • Muscle biopsy provides a definitive diagnosis; however, it is rarely recommended except in difficult cases when serology tests are unhelpful.
    • Obtain a 0.5- to 1-g muscle biopsy specimen from the deltoid or gastrocnemius muscle because these are most easily accessible. The yield increases if the biopsy site is swollen or tender. Stain the specimen with hematoxylin and eosin (H&E) and examine multiple sections. Occasionally, larvae can be found after the muscle has been digested enzymatically.
    • If a biopsy is performed prior to larvae coiling (beyond day 17 of infection), worm tissue can be confused with muscle tissue.
    • A negative result does not necessarily exclude infection.
Previous
Next

Histologic Findings

A histologic examination may reveal destruction of skeletal muscles, including a basophilic degeneration of the fibers observed on H&E-stained sections. Dead, nonencapsulated parasites can be observed. Muscle cells contain small hemorrhages and an accumulation of inflammatory cells (eg, eosinophils, lymphocytes, macrophages).

The results of a histologic examination in myocardial muscle are consistent with an immune-mediated reaction. Parasites migrate through the myocardium but do not encyst; however, a strong inflammatory reaction occurs, with numerous eosinophils, erythrocytes, fibrin deposits, and foci of necrotic myocardium. A mild-to-moderate pericardial effusion may also be present. Perivascular collections of eosinophils, lymphocytes, macrophages, and polymorphonuclear leukocytes develop in the CNS and are associated with areas of ischemia. Larvae may be surrounded by astrocytes and microglial cells.

Previous
Next

Staging

Case definitions for human trichinosis include possible cases (not applicable), probable cases (patients who meet the clinical criteria and with an epidemiological link [below]), and confirmed cases (patients who meet the laboratory criteria and clinical criteria within the past 2 months).[1]

  • Clinical criteria - At least 3 of the following: (1) fever, (2) muscle soreness and pain, (3) gastrointestinal symptoms, (4) facial edema, (5) eosinophilia, or (6) subconjunctival, subungual, and retinal hemorrhages
  • Laboratory criteria - At least 1 of the following: (1) demonstration of Trichinella larvae in tissue obtained by muscle biopsy or (2) demonstration of Trichinella -specific antibody response by indirect immunofluorescence, ELISA, or Western blot
  • Epidemiological criteria - At least one of the following: (1) consumption of laboratory-confirmed parasitized meat, (2) consumption of potentially parasitized products from a laboratory-confirmed infected animal, or (3) epidemiological link to a laboratory-confirmed human case by exposure to the same common source

Algorithm for diagnosis of human acute trichinellosis

One symptom from group A or one from group B or C (below) indicates a very unlikely diagnosis. One symptom from group A or 2 from group B and 1 from group C indicate a suspected diagnosis. Three symptoms from group A and 1 from group C indicate a probable diagnosis. Three symptoms from group A and 2 from group C indicate a highly probable diagnosis. A diagnosis is considered confirmed in patients with 3 symptoms from group A, 2 from group C, and 1 from group D or any of group A or B, 1 from group C, and 1 from group D.[1]

  • A - Fever, eyelid and/or facial edema, myalgia
  • B - Diarrhea, neurological signs, cardiological signs, conjunctivitis, subungual hemorrhages, cutaneous rash
  • C - Eosinophilia (>1000 eosinophils/mL) and/or increased total immunoglobulin E (IgE) levels, increased levels of muscular enzymes
  • D - Positive serology (with a highly specific test), seroconversion, positive muscular biopsy result
Previous
 
 
Contributor Information and Disclosures
Author

Clinton Murray, MD  Program Director, Infectious Disease Fellowship, San Antonio Uniformed Services Health Education Consortium

Clinton Murray, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Association of Military Surgeons of the US, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Pranatharthi Haran Chandrasekar, MBBS, MD  Professor, Department of Internal Medicine, Director of Infectious Disease Fellowship, Harper Hospital, Wayne State University School of Medicine

Pranatharthi Haran Chandrasekar, MBBS, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

John L Brusch, MD, FACP  Assistant Professor of Medicine, Harvard Medical School; Consulting Staff, Department of Medicine and Infectious Disease Service, Cambridge Health Alliance

John L Brusch, MD, FACP is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. Gottstein B, Pozio E, Nöckler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev. Jan 2009;22(1):127-45, Table of Contents. [Medline].

  2. Pozio E, Hoberg E, La Rosa G, Zarlenga DS. Molecular taxonomy, phylogeny and biogeography of nematodes belonging to the Trichinella genus. Infect Genet Evol. Jul 2009;9(4):606-16. [Medline].

  3. Roy SL, Lopez AS, Schantz PM. Trichinellosis surveillance--United States, 1997-2001. MMWR Surveill Summ. Jul 25 2003;52(6):1-8. [Medline].

  4. Hill DE, Samuel MD, Nolden CA, Sundar N, Zarlenga DS, Dubey JP. Trichinella murrelli in scavenging mammals from south-central Wisconsin, USA. J Wildl Dis. Jul 2008;44(3):629-35. [Medline].

  5. Blaga R, Durand B, Antoniu S, Gherman C, Cretu CM, Cozma V. A dramatic increase in the incidence of human trichinellosis in Romania over the past 25 years: impact of political changes and regional food habits. Am J Trop Med Hyg. May 2007;76(5):983-6. [Medline].

  6. Westrell T, Ciampa N, Boelaert F, Helwigh B, Korsgaard H, Chríel M. Zoonotic infections in Europe in 2007: a summary of the EFSA-ECDC annual report. Euro Surveill. Jan 22 2009;14(3):[Medline].

  7. Tassi C, Materazzi L, Pozio E, Bruschi F. Creatine kinase isoenzymes in human trichinellosis. Clin Chim Acta. Aug 14 1995;239(2):197-202. [Medline].

  8. Dupouy-Camet J, Kociecka W, Bruschi F, et al. Opinion on the diagnosis and treatment of human trichinellosis. Expert Opin Pharmacother. Aug 2002;3(8):1117-30. [Medline].

  9. Fourestie V, Bougnoux ME, Ancelle T, et al. Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res. 1988;75(1):36-41. [Medline].

  10. Med Lett Drugs Ther. Drugs for parasitic infections. Med Lett Drugs Ther. Jan 2 1998;40(1017):1-12. [Medline].

  11. Watt G, Saisorn S, Jongsakul K, et al. Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis. J Infect Dis. Jul 2000;182(1):371-4. [Medline].

  12. Al-Sherbiny MM, Farrag AA, Fayad MH, et al. Application and assessment of a dipstick assay in the diagnosis of hydatidosis and trichinosis. Parasitol Res. Jun 2004;93(2):87-95. [Medline].

  13. Cleri DJ, Ricketti AJ, Ramos-Bonner LS, Vernalco JR. Trichinosis (Part I and II). Infect Dis Pract. 2005;29:439-444 and 451-459.

  14. Compton SJ, Celum CL, Lee C, et al. Trichinosis with ventilatory failure and persistent myocarditis. Clin Infect Dis. Apr 1993;16(4):500-4. [Medline].

  15. Dalessio DJ, Wolff HG. Trichinella spiralis infection of the central nervous system. Report of a case and review of the literature. Arch Neurol. Apr 1961;4:407-17. [Medline].

  16. Froscher W, Gullotta F, Saathoff M, Tackmann W. Chronic trichinosis. Clinical, bioptic, serological and electromyographic observations. Eur Neurol. 1988;28(4):221-6. [Medline].

  17. Gottstein B, Pozio E, Nöckler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev. Jan 2009;22(1):127-45, Table of Contents. [Medline].

  18. Harms G, Binz P, Feldmeier H, et al. Trichinosis: a prospective controlled study of patients ten years after acute infection. Clin Infect Dis. Oct 1993;17(4):637-43. [Medline].

  19. Jongwutiwes S, Chantachum N, Kraivichian P, et al. First outbreak of human trichinellosis caused by Trichinella pseudospiralis. Clin Infect Dis. Jan 1998;26(1):111-5. [Medline].

  20. Kozar Z, Kozar M. Dynamics and persistence of antibodies in trichinellosis. Wiad Parazytol. 1968;14(2):171-85. [Medline].

  21. Louthrenoo W, Mahanuphab P, Sanguanmitra P, Thamprasert K. Trichinosis mimicking polymyositis in a patient with human immunodeficiency virus infection. Br J Rheumatol. 32(11):1025-6. [Medline].

  22. MacLean JD, Viallet J, Law C, Staudt M. Trichinosis in the Canadian Arctic: report of five outbreaks and a new clinical syndrome. J Infect Dis. Sep 1989;160(3):513-20. [Medline].

  23. Mawhorter SD, Kazura JW. Trichinosis of the central nervous system. Semin Neurol. Jun 1993;13(2):148-52. [Medline].

  24. McAuley JB, Michelson MK, Hightower AW, et al. A trichinosis outbreak among Southeast Asian refugees. Am J Epidemiol. Jun 15 1992;135(12):1404-10. [Medline].

  25. McAuley JB, Michelson MK, Schantz PM. Trichinella infection in travelers. J Infect Dis. Nov 1991;164(5):1013-6. [Medline].

  26. Pozio E, Darwin Murrell K. Systematics and epidemiology of trichinella. Adv Parasitol. 2006;63:367-439. [Medline].

  27. Pozio E, La Rosa G, Murrell KD, Lichtenfels JR. Taxonomic revision of the genus Trichinella. J Parasitol. Aug 1992;78(4):654-9. [Medline].

  28. Rosenblatt JE. Laboratory diagnosis of infections due to blood and tissue parasites. Clin Infect Dis. Oct 1 2009;49(7):1103-8. [Medline].

  29. Taylor WR, Tran GV, Nguyen TQ, Dang DV, Nguyen VK, Nguyen CT, et al. Acute febrile myalgia in Vietnam due to trichinellosis following the consumption of raw pork. Clin Infect Dis. Oct 1 2009;49(7):e79-83. [Medline].

  30. Tint D, Cocuz ME, Ortan OF, Niculescu MD, Radoi M. Cardiac involvement in trichinellosis: a case of left ventricular thrombosis. Am J Trop Med Hyg. Aug 2009;81(2):313-6. [Medline].

  31. Viallet J, MacLean JD, Goresky CA, et al. Arctic trichinosis presenting as prolonged diarrhea. Gastroenterology. Oct 1986;91(4):938-46. [Medline].

Previous
Next
 
Trichinosis. Life cycle of Trichinella species parasite. (Image courtesy of the CDC)
Table. Important Characteristics of Trichinella Species
Species Distribution Major Host Reservoir Infectivity Resistance to Freezing
T spiralis (T1)CosmopolitanSwine, wild boar, bear, horse, foxHighNone
Trichinella nativa (T2)ArcticBear, horseHighHigh
Trichinella britovi (T3)TemperateWild boar, horseModerateNone
Trichinella pseudospiralis (T4)CosmopolitanBirds, omnivorous mammalsModerateNone
Trichinella murrelli (T5)Temperate, near arcticBearLowLow
Trichinella nelsoni (T7)TropicalWarthogHighNone
Trichinella papuae (T10)Papua New GuineaWarthogModerateNone
Trichinella zimbabwensis (T11)Central AfricaCrocodilesUnknownNone
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.